Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07408479

Impact of Starch Digestibility on Glycemic Variability and Control, Cardiometabolic and Inflammatory Profiles, Microbiota and Intestinal Health in Subjects With Insulin Resistance

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Mondelēz International, Inc. · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

To study the potential impact of a diet rich in both Slowly Digestible Starch (SDS) and Resistant Starch (RS), we propose a 2-month nutritional intervention study in which we will study the evolution of carbohydrate variability and metabolism and health-related parameters in 40 volunteers with insulin resistance. Regular sampling of blood, urine and faeces as well as continuous measurement of blood glucose levels will be performed to assess changes in blood glucose levels, insulin resistance, lipid metabolism, inflammation and the composition of the microbiota following the introduction of starch products rich in SDS and RS into the diet.

Conditions

Interventions

TypeNameDescription
OTHERBalanced diet high in Slowly Digestible Starch and Resistant StarchDiet where all the starchy foods were selected based on their SDS and RS content. This diet needs to be easy to apply by subjects. It will be consumed during 2 months
OTHERBalanced diet low in Slowly Digestible Starch and Resistant StarchDiet where all the starchy foods were selected based on their SDS and RS content. This diet needs to be easy to apply by subjects. It will be consumed during 2 months

Timeline

Start date
2025-11-15
Primary completion
2027-12-01
Completion
2028-07-01
First posted
2026-02-13
Last updated
2026-02-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07408479. Inclusion in this directory is not an endorsement.